Pathophysiology of COVID-19: Why Children Fare Better than Adults?Review Article Published on 2020-05-142023-06-14 Journal: Indian journal of pediatrics [Category] MERS, SARS, [키워드] ACE-2 Adaptive immunity Innate immunity Pathogenesis SARS-CoV2 [DOI] 10.1007/s12098-020-03322-y PMC 바로가기 [Article Type] Review Article
Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19Review Published on 2020-05-142022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] addition Antiviral antiviral immunity clinical observation coronavirus COVID-19 Cytokine storm Cytopathic effect develop Disease progression disease severity effort explain Factor Host host immune system hyper-inflammatory response hypothese immune response immunomodulating drug Infection insight Interaction Intervention key factor knowledge management Mild morbidity and mortality Mortality New coronavirus no symptoms outbreak Pathogenesis Patient pharmacologic treatments Potential raised rationale recent recent finding SARS-CoV-2 SARS-CoV2 severe disease Strategy T cell repertoire the disease virus [DOI] 10.3390/vaccines8020224 PMC 바로가기 [Article Type] Review
Prediction of the COVID-19 Pandemic for the Top 15 Affected Countries: Advanced Autoregressive Integrated Moving Average (ARIMA) ModelOriginal Paper Published on 2020-05-132022-10-31 Journal: JMIR Public Health and Surveillance [Category] COVID-19, MERS, [키워드] affected Analysis ARIMA ARIMA models average Brazil China city confidence interval confirmed case confirmed cases coronavirus coronavirus disease country COVID-19 COVID-19 disease COVID-19 infection criterion cumulative death death rate deaths faster Forecast France Germany identify include information intensity Iran Italy mathematical Model mortality rate much higher Netherlands objective pandemic predict predicted prediction provide reported Result Russia SARS-CoV2 Spain Spread stratified Switzerland the disease The United States trajectory Turkey United Kingdom United States was done was used Wuhan [DOI] 10.2196/19115 PMC 바로가기 [Article Type] Original Paper
Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroidsArticle Published on 2020-05-082022-10-04 Journal: International immunopharmacology [Category] MERS, SARS, 임상, 치료법, [키워드] accelerate anti-IL6 antibody benefit cell entry Characteristics clinical benefit Controlled clinical trial correlated Corticosteroid Corticosteroids COVID-19 COVID-19-related death cytokine essential element fatal disease humans Hypothesis IL6 immune system Immunoglobulin immunoglobulins immunosuppressive IMPROVE Inflammation interleukin 6 monoclonal antibody Novel coronavirus outcomes Patient patients with COVID-19 pro-inflammatory cytokine Prognosis prognosis of patient rationale reduce SARS-CoV2 severe COVID-19 severity shown target targeted therapy therapeutic option therapy Treatment use of corticosteroid Viral load with COVID-19 [DOI] 10.1016/j.intimp.2020.106560 PMC 바로가기 [Article Type] Article
Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian CohortArticle Published on 2020-05-072022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] absence activated acute respiratory illness acute respiratory syndrome Admission age alteration of hemostasis benefit C-reactive protein China clinical clinical form clotting clotting factor Cohort control group coronavirus coronavirus disease COVID-19 COVID-19 patient COVID-19 patients D-dimer Department develop Disseminated intravascular coagulation Emergency enrolled Factor fibrinogen fibrinogen level groups highly pathogenic increased risk induce Italian Laboratory marker material non-COVID-19 patient outbreak parameter Patient patients PCR Platelet presentation prognostic Prognostic marker Prothrombin time risk stratification SARS-CoV2 Spread statistically significant Surveillance the disease Treatment two group value was used [DOI] 10.3390/jcm9051371 PMC 바로가기 [Article Type] Article
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventionsArticle Published on 2020-05-042023-06-15 Journal: Autoimmunity reviews [Category] MERS, SARS, [키워드] Anakinra COVID-19 Cytokine storm IL-1 IL-6 SARS-CoV2 Tocilizumab type-I interferon [DOI] 10.1016/j.autrev.2020.102567 PMC 바로가기 [Article Type] Article
How Big Data and Artificial Intelligence Can Help Better Manage the COVID-19 PandemicCommunication Published on 2020-05-022022-10-30 Journal: International Journal of Environmental Research an [Category] COVID-19, MERS, [키워드] artificial artificial intelligence Better big data Can COVID-19 COVID-19 pandemic effort Epidemic Epidemiology handling Health help information intelligence molecular Novel coronavirus Organisms outbreak pandemic public health responsible SARS-CoV2 Surveillance viral outbreak World Health Organization [DOI] 10.3390/ijerph17093176 PMC 바로가기 [Article Type] Communication
Immune-epidemiological parameters of the novel coronavirus – a perspectiveReview Published on 2020-05-012023-07-14 Journal: Expert review of clinical immunology [Category] SARS, [키워드] 2019-nCoV COVID-19 immune-epidemiology. Novel coronavirus SARS-CoV2 [DOI] 10.1080/1744666X.2020.1750954 PMC 바로가기 [Article Type] Review
Over view for the truth of COVID -19 pandemic: A guide for the Pathologists, Health care workers and community’Short Communication Published on 2020-05-012022-10-29 Journal: Pakistan Journal of Medical Sciences [Category] COVID-19, [키워드] acute respiratory syndrome Avoiding close contact Coronavirus-2 COVID COVID-19 equipment eyes Face masks Health Health care healthy human behavior immune system Laboratory Laboratory Staffs measure Measures Mortality number of infected over pandemic pathologist Pathologists PPE Protective rising risk SARS-CoV-2 SARS-CoV2 social distancing Travel virus spread while [DOI] 10.12669/pjms.36.COVID19-S4.2519 PMC 바로가기 [Article Type] Short Communication
Indications regarding the management of interventional clinical trials with drugs during the current COVID-19 emergency in ItalyEditorial Published on 2020-04-302022-10-05 Journal: ESMO open [Category] SARS, 임상, [키워드] clinical trial clinical trials COVID-19 COVID-19 emergency drug indication Italy management oncology SARS-CoV2 [DOI] 10.1136/esmoopen-2020-000782 [Article Type] Editorial